medical cannabis solutions HEALTHCARE PROFESSIONALS GUIDE
|
|
- Laurel Hudson
- 5 years ago
- Views:
Transcription
1 medical cannabis solutions HEALTHCARE PROFESSIONALS GUIDE N A T U R A L C A R E G R O U P. C O M
2 inside What s Working with Natural Care 2 How Natural Care works for patients 5 How Natural Care works in senior care 7 Prescribing and administering medical cannabis 9 Why medical cannabis? 16
3 Working with Natural Care It s simple: we re here to improve your patients or residents quality of life, and to lighten your workload. We create personalized cannabis plans. Whether you prescribe medical cannabis or refer to a Natural Care prescriber, we ll incorporate your recommendations into a personalized patient plan that includes a careful dosing and titration schedule. We ll follow up with regular calls to your patient, resident or their caregiver to ensure everything s on track. We offer ongoing, on-demand support. Our nurses and educators are on call to answer your questions. Your patients, residents and their caregivers can also call us directly for help with their personalized cannabis plans, licensed producer registration, orders, refills and more. NATURALCAREGROUP.COM 2
4 first We put patients We recommend the most suitable products for individual patients. We are completely licensed producer-agnostic. We provide up-to-date cannabis education. The Natural Care advantage starts with education: we offer comprehensive cannabis education for doctors, nurses and healthcare providers; we also conduct sessions at retirement and long-term care homes, community groups and more. We are experts in senior care and cannabis. Our team combines decades of retirement and longterm care management experience with seniorspecific healthcare expertise and medical cannabis savvy. We work directly with retirement and long-term care homes. We provide customized education sessions, as well as policy and administrative support. We make managing medical cannabis easy for homes and staff. We don t charge for our services. No matter how complex your patients or residents needs, our comprehensive services are always free. NATURALCAREGROUP.COM 4
5 How Natural Care works for patients We guide patients through every step of the prescription, registration, ordering and refill process. ASSESS PRESCRIBE PERSONALIZE REGISTER ORDER SUPPORT Meet with a nurse practitioner or doctor in person or online. If medical cannabis is suitable, the patient s MD or a Natural Care MD or NP generates a prescription. Based on the prescription notes, a Natural Care nurse creates an individualized cannabis medication plan. Based on the cannabis medication plan, Natural Care completes registration with the most suitable licensed producer(s). Natural Care s patient care team offers guidance throughout the ordering and refill process. Natural Care provides ongoing support for the life of every prescription. NATURALCAREGROUP.COM 6
6 Provide medical cannabis prescriptions How Natural Care works in senior care Medical cannabis and its legal bureaucracy can be complicated. WE MAKE IT SEAMLESS. Every home is different, and we work quickly to implement a customized medical cannabis program designed to improve residents quality of life and lighten staff workload. From training to policy implementation, medical administration, documentation and more, we ve got it covered. Update home and residence policies and procedures as needed Provide ondemand phone and support to staff, residents, families and caregivers NATURAL CARE S COMPLIMENTARY SERVICES Provide ongoing education with staff, residents, families and caregivers Create personalized cannabis medication plans Complete patients LP registration NATURALCAREGROUP.COM 8
7 fast Prescribing and facts administering medical cannabis The rules and best practices around medical cannabis are just like other prescribed drugs. Potential medical benefits Likely beneficial for Potential side effects CBD Cannabidiol only Analgesic Anti-inflammatory Antiemetic Antispasmodic Anti-epileptic Anxiolytic Reduces THC-induced psychoactivity/anxiety Anxiety Depression Chronic pain Spasticity associated with MS, ALS and spinal cord injury Epilepsy Inflammation & inflammatory conditions, including IBS, ulcerative colitis, Crohn s, fibromyalgia, rheumatoid arthritis PTSD Cannabidiol exhibits biphasic properties most therapeutic effects are found at lower doses; slow titration may mitigate potential side effects. Somnolence, changes in appetite/weight In rare cases, may cause diarrhea CBD:THC Cannabidiol and tetrahydrocannabinol blends Analgesic Anti-inflammatory Antispasmodic Antiemetic Appetite stimulant Soporific Mood elevator Decreases intestinal motility Chronic pain Nausea & vomiting Anorexia Spasticity associated with MS, ALS and spinal cord injury Inflammation & inflammatory conditions, including IBS, ulcerative colitis, Crohn s, fibromyalgia, rheumatoid arthritis Limited evidence suggests that THC in particular may be beneficial for insomnia, neuropathic pain, nausea/vomiting and PTSD. It is recommended to start with CBD and introduce 1:1 in the evenings if needed for insomnia, PTSD, etc. Tetrahydrocannabinol exhibits biphasic properties most therapeutic effects are found at lower doses; slow titration may mitigate potential side effects. Anxiety, disorientation, intoxication, somnolence May induce psychosis in susceptible individuals (personal or family history) In rare cases, may cause orthostatic hypotension, depression, ataxia/ dyscoordination, tachycardia, cannabis hyperemesis, diarrhea NATURALCAREGROUP.COM 10
8 Contraindications Drug interactions CBD Cannabidiol only Unsuitable for pregnant and breastfeeding patients Many interactions can be mitigated in complex patients with polypharmacy by slowly titrating. CYP450 enzyme inhibitor May interact with anti-epileptic drugs; close monitoring of AED levels and LFTs advised Potent inhibitor of CYP3A4 and CYP2D6; may increase serum concentrations of macrolides, calcium channel blockers, benzodiazepines, cyclosporine, sildenafil (and other PDE5 inhibitors), antihistamines, haloperidol, antiretrovirals, and some statins (atorvastatin and simvastatin, but not pravastatin or rosuvastatin); may increase serum concentrations of SSRIs, tricyclic antidepressants, antipsychotics, beta blockers and opioids (including codeine and oxycodone) CBD:THC Cannabidiol and tetrahydrocannabinol blends Acute psychosis, severe/unstable psychiatric conditions, actively suicidal History of THC-induced hyperemesis Under age 25 Severe cardiovascular, immunological, liver or kidney disease (especially in acute illness can exacerbate arrhythmias) Caution should be exercised in patients with history of drug or alcohol addiction (although recent evidence points to cannabis as potential harm reduction substitution) Unsuitable for pregnant and breastfeeding patients Many interactions can be mitigated in complex patients with polypharmacy by slowly titrating. CYP450 enzyme inhibitor CYP1A2 inducer (theoretically can decrease serum concentrations of clozapine, duloxetine, naproxen, cyclobenzaprine, olanzapine, haloperidol, and chlorpromazine) Potential interaction with medications metabolized by P450 enzymes (2C9, 2C19, 3A4), including antidepressants, proton pump inhibitors, cimetidine, macrolides, antimycotics, calcium antagonists, HIV protease inhibitors, amiodarone, isoniazid The following drugs may decrease the availability of THC: carbamazepine, rifampicin, phenobarbital, phenytoin, primidone, rifabutin, St. John s wort Safety No reports of abuse or dependence; no public health risk. Minimal risk of dependence, similar to anxyolitics at 9%. (Versus 21% for opioids, 23% for alcohol and 68% for tobacco.) Dosing Oils & capsules/softgels Daytime dosing, non-intoxicating Daily dosing Start at 8-10mg/day Titrate by 5 mg as tolerated *Unless you wish otherwise, a Natural Care nurse will create a personalized dosing and titration schedule for every patient, with regular telephone check-ins and follow-up, at no charge. Oils & capsules/softgels Nighttime dosing, mild psychoactive, sedating effects At hs only to start Start at 2.5 mg, titrate by 1mg q 2-3 days as tolerated and to desired effect *Unless you wish otherwise, a Natural Care nurse will create a personalized dosing and titration schedule for every patient, with regular telephone check-ins and follow-up, at no charge. NATURALCAREGROUP.COM 12
9 Onset and duration of effects INHALATION ORAL INGESTION Product Flower Oils, capsules, softgels Onset Less than 5 min 30 min to 2 hrs Peak effect Less than 15 min 2 to 4 hrs Duration 2 to 4 hrs 4 to 8 hrs Notes Driving after cannabis use Ingestion methods are generally preferred for consistent dosing and longer impact. Some patients may desire inhalation for acute and breakout pain. Vapourizing recommended (not smoking). Patients should be counselled not to drive for 4 hours after inhalation, or for 8 hours if euphoria is experienced. Oils Administered sublingually, swallowed or mixed with food. Capsules & softgels Ingested as usual. Patients should be counselled not to drive for 6 hours after ingestion, or for 8 hours if euphoria is experienced. NATURALCAREGROUP.COM 14
10 Cannabis treats so many symptoms and conditions that a single cannabis prescription may reduce total prescription load. why cannabis? According to the Canadian Institute for Health Information, nearly a quarter of Canadians 65 and up take 10 or more prescription drugs: Seniors who were prescribed 10+ drugs were more likely to be hospitalized for an adverse drug reaction over five times more likely than seniors who were prescribed fewer drugs. 1 medical N A T U R A L C A R E G R O U P. C O M 16
11 Why medical cannabis? Medical cannabis patients report significant pain relief. In an observational study of over 2700 medical cannabis patients, conducted over three years at a nursing home in Israel 2, 93.7 % of respondents reported an improvement in their condition after six months. On a scale of one to 10, reported pain levels decreased from a median of eight to a median of four, representing a 50% REDUCTION IN PAIN. A cannabis prescription can significantly reduce opioid reliance, sometimes replacing opioid drugs entirely. Medical cannabis is safe. Fatal cannabis overdose is impossible. 4 The results of the Israel nursing home study were published in The European Journal of Internal Medicine. 5 Conclusion: Our study finds that the therapeutic use of cannabis is safe and efficacious in the elderly population. s F E a 18.1% of older adult patients stopped using opioid analgesics or reduced their dose after six months. 3 it's NATURALCAREGROUP.COM 18
12 Cannabis use is associated with better quality of life in patients with chronic pain. 6 Get your life back In a 2016 retrospective study of chronic pain patients, published in The Clinical Journal of Pain, researchers found a clinically significant association between cannabis use and better quality of life, as well as reduced opioid use and a better side effect profile when compared with opioid drugs. 7 A National Academies review also found that cannabis has a clinically meaningful effect on pain. 8 Cannabis treatment in agitated patients may reduce caregiver burnout. In a 14-week trial of Alzheimer s patients treated with the synthetic cannabinoid nabilone 9, Sunnybrook Hospital researchers found significantly reduced agitation compared with a placebo group and significantly improved behavioural symptoms overall. Researchers also found that this reduced patient agitation and aggression was associated with a clinically meaningful reduction in caregiver stress. NATURALCAREGROUP.COM 20
13 Contact us Join the growing number of healthcare professionals referring to Natural Care. Your patients and residents will thank you! J i o N us No matter how complex your patients or residents needs, our comprehensive services are always free. us at: support@naturalcaregroup.com Call us at: to learn more DOWNLOAD REFERRAL FORMS Please visit naturalcaregroup.com/forms to download new forms, or call or us and we ll send some your way. NATURALCAREGROUP.COM 22
14 FOOTNOTES 1. The Canadian Institute for Health Information. May 17, in 4 Canadian seniors prescribed 10 or more drugs. Available online at: 2. Abuhasira R et al Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly, European Journal of Internal Medicine. Available online at: nih.gov/pubmed/ Ibid 4. To date, there has never been a recorded death from ingesting too much cannabis. It is estimated that a fatal dose of marijuana would require the (physically impossible) ingestion of fifteen hundred pounds in fifteen minutes, according to David Schmader, author of Weed: The User s Guide and published at 5. Abuhasira R et al Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine. Available online at: nih.gov/pubmed/ Bellnier T et al Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Mental Health Clinician. Available online at: Elliott DA, et al Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy. Supportive Care in Cancer. Available online at: ncbi.nlm.nih.gov/pubmed/ Fiz J et al Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS One. Available online at: pubmed/ Haroutounian S et al The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study. The Clinical Journal of Pain. Available online at: National Academies of Sciences, Engineering, and Medicine The health effects of cannabis and cannabinoids: Current state of evidence and recommendations for research. The National Academies Press. Available online at: reports/2017/health-effects-of-cannabis-and-cannabinoids.aspx 7. Haroutounian S et al The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study. The Clinical Journal of Pain. Available online at: 8. National Academies of Sciences, Engineering, and Medicine The health effects of cannabis and cannabinoids: Current state of evidence and recommendations for research. The National Academies Press. Available online at: reports/2017/health-effects-of-cannabis-and-cannabinoids.aspx 9. Funded by The Alzheimer s Drug Discovery Foundation, the trial was conducted at Sunnybrook Hospital using the synthetic cannabinoid nabilone. Researchers noted that although it is too soon to extend the results to medical cannabis, the results are nevertheless promising. Learn more from the study s authors here: and here This information is not intended to be a substitute for the advice of a healthcare professional nor a recommendation of any particular treatment regimen. Please consult with your healthcare practioners for professional advice pertaining to your particular condition. NATURALCAREGROUP.COM
15 N A T U R A L C A R E G R O U P. C O M
Use of Cannabinoids in Medical Practice
Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced
More informationEMERGENCE OF CANNABIDIOL IN MEDICINE
EMERGENCE OF CANNABIDIOL IN MEDICINE Sarah Katta, DO Hematology/Oncology Associate Professor of Medicine-University of Central Florida Southwest Cancer Center Orlando, Florida BACKGROUND Cannabis-There
More informationThe Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy
The Effects known & unknown of Marijuana in Older Adults Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy Learning Objectives 1. Review various dosing strategies for medical
More informationMedicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer
Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance
More informationPOLICY NUMBER: POL 153
Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines
More informationMedicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose
Medicinal Cannabis Patient Log Book Record your cannabis use and find the right dose 1 Introduction A federal system is in place for medicinal cannabis that is distinct from recreational sales. To get
More informationMedical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University
Medical Cannabis use in the Older Patient Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University Disclosure Relationships with commercial interests: Grants/Research Support: none Speakers
More informationI would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people
I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid
More informationConsumer Information Cannabis (Marihuana, marijuana)
Consumer Information Cannabis (Marihuana, marijuana) The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes. The
More informationDr. Meldon Kahan. Women s College Hospital. with PIA LAW
with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director
More informationMedical Cannabis use in the Older Patient
Medical Cannabis use in the Older Patient Dr. Amanjot Sidhu Division of Geriatric Medicine McMaster University Audience Poll What is the fastest-growing demographic of cannabis users? a) Ages 14-23 b)
More informationCannabinoids: access and symptom management in cancer
Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationJames McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada
James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationLGP CLASSIC Oil Products
LGP CLASSIC Oil Products Patient Information Leaflet (PIL) PRODUCT RANGE Medicinal Cannabis Oil Extract LGP CLASSIC 10:10 LGP CLASSIC 10:15 LGP CLASSIC 20:5 What is in this leaflet Please read this leaflet
More informationJuly 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine
MEDICAL CANNABIS FOR NEUROLOGICAL DISEASES July 15 TH, 2017 ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine GOALS AND OBJECTIVES
More informationReefer Madness version 3.0*
Reefer Madness version 3.0* Presenter Disclosure *Original Reefer Madness: FMF 2014 by R. Dubin, Sharon Cirone and Mel Kahan Update on Health Canada s MMPR and the use of cannabis for medical conditions
More informationMedical Marijuana Consent Form
Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal
More informationMedical vs Recreational Use of Cannabis. 11 th December 2017
1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationSmoking Cessation Pharmacotherapy Guidelines
Smoking Cessation Pharmacotherapy Guidelines INTRODUCTION This guideline is based on public health guidance 10 Smoking Cessation Services issued by the National Institute for Health and Clinical Excellence
More informationObjectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access
Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology
More informationImportant Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
More informationOXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?
OXZGEN FAQ s What is the Endocannabinoid System? Discovered only a few decades ago, the endocannabinoid system (ECS) is one of the most important physiological systems in our body. It consists of a group
More informationINITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationClinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD
Clinical Education Initiative Support@ceitraining.org MEDICAL MARIJUANA 101 Speaker: Patricia Reed, PharmD 8/2/2017 Medical Marijuana 101 [video transcript] 00:00:12 - So we'll get started. Disclosures
More informationMarijuana and the Workplace : Changing Times
Marijuana and the Workplace : Changing Times By: Stéphane Thiffeault 2018 AMCTO Conference Blue Mountain Resort June 12, 2018 Presentation Outline Current Status of Cannabis Some Facts and Statistics Summer
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationMedical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.
Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure
More informationMedicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationCANNABIS AND PAIN. Debra Kimless, M.D. Medical Director, ForwardGro MAOP Annual Meeting September 14, 2018
CANNABIS AND PAIN Debra Kimless, M.D. Medical Director, ForwardGro MAOP Annual Meeting September 14, 2018 FDA APPROVAL: PREGABALIN, DULOXETINE, MILNACIPRAN FOR FIBROMYALGIA PREGABALIN, DULOXETINE FOR
More informationFaculty/Presenter Disclosure
Faculty/Presenter Disclosure Faculty: Philippe Lucas Relationships with commercial interests: Philippe Lucas is a Research Affilliate with the Centre for Addictions Research of BC, as well as VP, Patient
More informationMedical Marijuana Update Chris Belletieri, DO
Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationLegalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine
Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics
More informationMedical Cannabis & Seniors - 101
Medical Cannabis & Seniors - 101 Presented by: Shannon O Hearn MSc., Clinical Research Project Manager Date: April 13 th, 2017 Agenda Who is MedReleaf? How Cannabis is currently regulated in Canada The
More informationAct 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
More informationHistory Of Medical Cannabis
History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction
More informationPATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:
PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: / / Gender: Male Female Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: Email: Primary
More informationCannabis for Medical Purposes
College of Physicians and Surgeons of British Columbia Cannabis for Medical Purposes Preamble This document is a standard of the Board of the College of Physicians and Surgeons of British Columbia. College
More informationWelcome to MedWell. Patient Information. Name: Address: City: State: Zip Code: !Other. Name: Address: City: State:
1 Welcome to MedWell Patient Information Date: Name: Date of Birth: / / Address: City: State: Zip Code: Home Phone: ( ) - Cell Phone: ( ) - Email: Gender:! Male! Female Last 4 of Social Security Number
More informationTreating Pain and Depression
Treating Pain and Depression Without Getting Depressed Joseph P, Arpaia, MD www.jparpaiamd.com More than 50% of patients with chronic pain also have clinically significant depression. Interestingly that
More informationMedical Marijuana: Hype versus Evidence
Medical Marijuana: Hype versus Evidence Monica Malec, MD The University of Chicago, Department of Medicine Section of Geriatrics and Palliative Medicine Objectives Understand the requirements for physician
More informationThe Highs and Lows of Medical Marijuana
The Highs and Lows of Medical Marijuana Jill Vargo Cavalet, MHS, PA-C Marijuana use is prevalent worldwide yet remains controversial in health care. The general public often regards marijuana as a benign
More informationSubstances under Surveillance
Substances under Surveillance The following substances are under surveillance by the World Health Organization (WHO) as they are considered to have the potential to cause public health harm. For ease of
More informationCBD and Your Health.
CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear
More informationDr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationPetitions to Add Qualifying Medical Conditions to the Medical Cannabis Program A REPORT TO THE COMMISSIONER OF HEALTH
Petitions to Add Qualifying Medical Conditions to the Medical Cannabis Program A REPORT TO THE COMMISSIONER OF HEALTH 2018 FOREWORD This report was produced by the medical cannabis citizens review panel
More informationGuidance for the use of. medicinal cannabis. in Australia. Patient information
Guidance for the use of medicinal cannabis in Australia Patient information Version 1, December 2017 Copyright Commonwealth of Australia 2017 This work is copyright. You may reproduce the whole or part
More informationInterface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE
Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable
More informationWhat is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration
What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,
More informationMedical Cannabis: A Patient Primer
Medical Cannabis: A Patient Primer This primer is meant for documented patients who are using medicinal cannabis or considering using it in the future. The information provided about this medication in
More informationLife s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE
Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE With the legalization of recreational cannabis upon us in Canada, our conversation about cannabis use is changing. It s not
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationNorthern California Chapter, ACP Update In Medicine
Northern California Chapter, ACP Update In Medicine Kathleen A. Kenny MD Clinical Associate Professor of Medicine Primary Care and Population Health November 3, 2018 UPDATE ON MARIJUANA Kathleen A. Kenny
More informationIs there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital
Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital Disclosures No relevant financial or relationship disclosures
More informationMedical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids
Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State
More informationMedical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids
Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State
More informationEMERGING ISSUES IN SMOKING CESSATION
EMERGING ISSUES IN SMOKING CESSATION Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe, CM, MD University
More informationGENERAL PRACTITIONER (GP) SUPPORT PACK
Document Reference MM 050 Integrated Care Pathway (ICP) for the Management of clozapine GENERAL PRACTITIONER (GP) SUPPORT PACK One pack to be printed for each patient initiated on clozapine treatment,
More informationCANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS
CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds
More informationPrescription Opioid Addiction
CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett
More informationKnock Out Opioid Abuse in New Jersey:
Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids
More informationCannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017
Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More informationAustralian Medicinal Cannabis Pricing Analysis
Australian Medicinal Cannabis Pricing Analysis Q3 2018 cannabis access clinics » Entry level product prices fall by close to 50% over 12 months» Number of legal products available up threefold» Pharmacy
More informationThis is a duplicated text of a letter from GW Pharma Ltd. Contact the company for a copy of any references, attachments or enclosures.
Health Canada posts safety alerts, public health advisories, press releases and other notices from industry as a service to health professionals, consumers and other interested parties. Although Health
More informationDrug Interactions Year 2 Clinical Pharmacology
1 Drug Interactions Year 2 Clinical Pharmacology Prof Mark McKeage Department of Pharmacology & Clinical Pharmacology 2 Objectives Explain the potential for interacting drugs to cause beneficial and harmful
More informationImportant Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
More informationUse of Medical Marijuana in Cancer Treatment & Care
Use of Medical Marijuana in Cancer Treatment & Care Ronald Stram,MD Stram Center for Integrative Medicine April 2016 Introduction Board Certified Medical Doctor, Integrative and Functional Medicine 28
More informationPATIENT QUESTIONNAIRE
PATIENT QUESTIONNAIRE Personal Information Date Name Date of Birth Age Height Weight Gender: Male / Female Address City State / Zip Home Phone Cell phone Work phone E-mail address Do you currently have
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationMEDICAL MARIJUANA: WHAT S THE EVIDENCE?
MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y
More informationMedical Cannabinoids for the Management of Chronic Noncancer Pain
Medical Cannabinoids for the Management of Chronic Noncancer Pain Dr Mark A. Ware MBBS MSc McGill University 12 June 2018 Disclosures Grants: CanniMed Consulting: CHI Inc Emmes 1 Canadian Consortium for
More informationMedical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator
Medical Cannabis Program Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator Disclaimer The following information is based upon research of current studies. The Department of Health
More informationCORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/ January 2013
CORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/001 16 January 2013 1 4.2 Posology and method of administration (safety aspects only) Posology Elderly patients For oral preparations A dose adjustment
More informationWHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationScottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address
Scottsdale Certification Center Health History Questionnaire Name Gender M / F Date Date of Birth / / Phone Ht: ft in Wt Email Residential Address City State Zip Code Drivers Licence # Date Issued Mailing
More informationSusan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice
Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice Integrative Clinical Nutritionist, Laura Lagano MS, RDN, CDN
More informationUnderstanding Hemp Extracts and CBD Oil. Quality assurance, product selection, and serving size tracking.
Understanding Hemp Extracts and CBD Oil. Quality assurance, product selection, and serving size tracking. When selecting cannabis products, quality is the highest priority. Regulations in the hemp industry
More informationBudding Therapies: Medical Cannabis and its Uses
Budding Therapies: Medical Cannabis and its Uses MARIAH CADAVOS, PHARMD & VIVIAN NGUYEN, PHARMD PGY1 PHARMACY PRACTICE RESIDENTS FEBRUARY 10, 2019 1 Disclosures & Disclaimer Both presenters have nothing
More informationMarijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine
Marijuana DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine Objectives Describe marijuana laws in the state of Oregon and the nation List evidence available for
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationESCA: Cinacalcet (Mimpara )
ESCA: Cinacalcet (Mimpara ) Effective Shared Care Agreement for the Treatment of Primary hyperparathyroidism when parathyroidectomy is contraindicated or not clinically appropriate. Specialist details
More informationHistory of Medical Cannabis in Nursing
History of Medical Cannabis in Nursing Kristen Luttenberger RN, MSN, CCRN, APNc http://marijuanapolitics.com/wp-content/uploads/2016/07/caduceus-lg.jpg https://images-na.ssl-imagesamazon.com/images/i/41gtt5pb4el._sx314_bo1,204,203,200_.jpg
More informationMedicinal cannabis use among PLWH in the era of legalization
Medicinal cannabis use among PLWH in the era of legalization June 8, 2017 David Grelotti, MD Assistant Professor University of California, San Diego Center for Medicinal Cannabis Research Outline Overview
More informationCANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE
1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations
More informationNew Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationGabapentin and pregabalin
Pain CONCERN Medicines for long-term pain Gabapentin and pregabalin This leaflet is about gabapentin and pregabalin, two drugs which are part of a group sometimes called gabapentinoids. The leaflet will
More informationCannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)
Member of the Cannabaceae family of flowering plants (along with hops) sativa (v. sativa, indica, afghanica, ruderalis) Only females flowers contain high concentrations of psychoactive oils (cannabinoids)
More information39 th Expert Committee on Drug Dependence Process and recommendations
39 th Expert Committee on Drug Dependence Process and recommendations Dr Gilles Forte Essential Medicines and Health Products Department WHO role within the International Drug Conventions To recommend
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationCannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD
Cannabidiol as a potential treatment for anxiety disorders Esther Blessing, MD PhD Overview History and of cannabidiol (CBD) and cannabis Safety and tolerability of CBD CBD pharmacology Clinical need for
More information